Peter Attia· MD
the reality of it is BCG has never shown enough specificity to be a viable immunotherapy against cancer and it's for that reason I guess even if that's overly simplistic that I really doubt the BCG could have a meaningful impact on a virus because it requires just as much in specificity as it does for the immune system to attack cancer